| # | LCS | Reference
|
|---|
| 1 | 77 | DAMMANN R, 2000, NAT GENET, V25, P315 WoS
|
| 2 | 41 | LERMAN MI, 2000, CANCER RES, V60, P6116 WoS
|
| 3 | 40 | AGATHANGGELOU A, 2001, ONCOGENE, V20, P1509 WoS
|
| 4 | 32 | VIRMANI AK, 2000, J NATL CANCER I, V92, P1303 WoS
|
| 5 | 31 | WISTUBA II, 2000, CANCER RES, V60, P1949 WoS
|
| 6 | 27 | LO KW, 2001, CANCER RES, V61, P3877 WoS
|
| 7 | 26 | HERMAN JG, 1996, P NATL ACAD SCI USA, V93, P9821 WoS
|
| 8 | 26 | ZOCHBAUERMULLER S, 2001, CANCER RES, V61, P249 WoS
|
| 9 | 26 | VOS MD, 2000, J BIOL CHEM, V275, P35669 WoS
|
| 10 | 25 | DAMMANN R, 2001, CANCER RES, V61, P3105 WoS
|
| 11 | 24 | BAYLIN SB, 1998, ADV CANCER RES, V72, P141 WoS
|
| 12 | 21 | ZOCHBAUERMULLER S, 2001, CANCER RES, V61, P3581 WoS
|
| 13 | 20 | SEKIDO Y, 1998, ONCOGENE, V16, P3151 WoS
|
| 14 | 20 | ESTELLER M, 2001, CANCER RES, V61, P3225 WoS
|
| 15 | 19 | KOK K, 1997, ADV CANCER RES, V71, P27 WoS
|
| 16 | 18 | BELINSKY SA, 1998, P NATL ACAD SCI USA, V95, P11891 WoS
|
| 17 | 17 | BAYLIN SB, 2000, TRENDS GENET, V16, P168 WoS
|
| 18 | 16 | ESTELLER M, 1999, CANCER RES, V59, P67 WoS
|
| 19 | 15 | WISTUBA II, 1999, ONCOGENE, V18, P643 WoS
|
| 20 | 15 | DAMMANN R, 2001, ONCOGENE, V20, P3563 WoS
|
| 21 | 15 | PALMISANO WA, 2000, CANCER RES, V60, P5954 WoS
|
| 22 | 15 | ESTELLER M, 1999, CANCER RES, V59, P793 WoS
|
| 23 | 15 | JONES PA, 1999, NAT GENET, V21, P163 WoS
|
| 24 | 14 | GIRARD L, 2000, CANCER RES, V60, P4894 WoS
|
| 25 | 13 | WISTUBA II, 1997, J NATL CANCER I, V89, P1366 WoS
|
| 26 | 13 | SOZZI G, 1996, CELL, V85, P17 WoS
|
| 27 | 13 | TOYOOKA KO, 2001, CANCER RES, V61, P4556 WoS
|
| 28 | 13 | VAVVAS D, 1998, J BIOL CHEM, V273, P5439 WoS
|
| 29 | 13 | MERLO A, 1995, NAT MED, V1, P686 WoS
|
| 30 | 13 | WEI MH, 1996, CANCER RES, V56, P1487 WoS
|
| 31 | 12 | OHTA M, 1996, CELL, V84, P587 WoS
|
| 32 | 12 | COSTELLO JF, 2000, NAT GENET, V24, P132 WoS
|
| 33 | 11 | YOON JH, 2001, INT J CANCER, V94, P212 WoS
|
| 34 | 11 | LATIF F, 1993, SCIENCE, V260, P1317 WoS
|
| 35 | 11 | KIM ST, 1999, J BIOL CHEM, V274, P37538 WoS
|
| 36 | 11 | SUNDARESAN V, 1998, ONCOGENE, V17, P1723 WoS
|
| 37 | 10 | VIRMANI AK, 1998, GENE CHROMOSOME CANC, V21, P308 WoS
|
| 38 | 10 | ORTIZVEGA S, 2002, ONCOGENE, V21, P1381 WoS
|
| 39 | 10 | TANG XM, 2000, J NATL CANCER I, V92, P1511 WoS
|
| 40 | 10 | ESTELLER M, 1998, CANCER RES, V58, P4515 WoS
|
| 41 | 9 | HERMAN JG, 1994, P NATL ACAD SCI USA, V91, P9700 WoS
|
| 42 | 9 | MAO L, 1997, J NATL CANCER I, V89, P857 WoS
|
| 43 | 9 | WISTUBA II, 2000, CLIN CANCER RES, V6, P2604 WoS
|
| 44 | 9 | KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820 WoS
|
| 45 | 8 | KIM DH, 2001, CANCER RES, V61, P3419 WoS
|
| 46 | 8 | GRAFF JR, 1997, J BIOL CHEM, V272, P22322 WoS
|
| 47 | 8 | CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990 WoS
|
| 48 | 8 | FONG KM, 1997, CANCER RES, V57, P2256 WoS
|
| 49 | 8 | FULLWOOD P, 1999, CANCER RES, V59, P4662 WoS
|
| 50 | 8 | GNARRA JR, 1994, NAT GENET, V7, P85 WoS
|
| 51 | 8 | GREENLEE RT, 2001, CA-CANCER J CLIN, V51, P15 WoS
|
| 52 | 7 | PHELPS RM, 1996, J CELL BIOCH S, V24, P32 WoS
|
| 53 | 7 | WISTUBA II, 1999, CANCER RES, V59, P1973 WoS
|
| 54 | 7 | ROCHE J, 1996, ONCOGENE, V12, P1289 WoS
|
| 55 | 7 | SEKIDO Y, 1996, P NATL ACAD SCI USA, V93, P4120 WoS
|
| 56 | 7 | BOS JL, 1989, CANCER RES, V49, P4682 WoS
|
| 57 | 7 | TAKAHASHI T, 1989, SCIENCE, V246, P491 WoS
|
| 58 | 7 | SEKIDO Y, 1998, BIOCHIM BIOPHYS ACTA, V1378, P21 WoS
|
| 59 | 7 | ESTELLER M, 2000, J NATL CANCER I, V92, P564 WoS
|
| 60 | 7 | KILLARY AM, 1992, P NATL ACAD SCI USA, V89, P10877 WoS
|
| 61 | 7 | KERSTING M, 2000, J CLIN ONCOL, V18, P3221 WoS
|
| 62 | 7 | KURAMOCHI M, 2001, NAT GENET, V27, P427 WoS
|
| 63 | 7 | PONTING CP, 1996, TRENDS BIOCHEM SCI, V21, P422 WoS
|
| 64 | 7 | CLIFFORD SC, 1998, GENE CHROMOSOME CANC, V22, P200 WoS
|
| 65 | 6 | HUNG J, 1995, JAMA-J AM MED ASSOC, V273, P558 WoS
|
| 66 | 6 | JI L, 1999, CANCER RES, V59, P3333 WoS
|
| 67 | 6 | DALY MC, 1993, ONCOGENE, V8, P1721 WoS
|
| 68 | 6 | HIYAMA K, 1995, J NATL CANCER I, V87, P895 WoS
|
| 69 | 6 | CAGLE PT, 1997, AM J PATHOL, V150, P393 WoS
|
| 70 | 6 | TODD S, 1997, CANCER RES, V57, P1344 WoS
|
| 71 | 6 | SHIVAPURKAR N, 1999, CLIN CANCER RES, V5, P17 WoS
|
| 72 | 6 | SATO M, 1998, HUM GENET, V103, P96 WoS
|
| 73 | 6 | TSUCHIYA T, 2000, ONCOGENE, V19, P3642 WoS
|
| 74 | 6 | LOVELL M, 1999, CANCER RES, V59, P2182 WoS
|
| 75 | 6 | HIBI K, 1992, ONCOGENE, V7, P445 WoS
|
| 76 | 6 | RICHARDSON GE, 1993, SEMIN ONCOL, V20, P105 WoS
|
| 77 | 6 | LATIF F, 1992, GENE CHROMOSOME CANC, V5, P119 WoS
|
| 78 | 6 | MARTINEZ A, 2000, J CLIN PATHOL-MOL PA, V53, P137 WoS
|
| 79 | 6 | PARK IW, 1999, J NATL CANCER I, V91, P1863 WoS
|
| 80 | 6 | VANDENBERG A, 1997, GENE CHROMOSOME CANC, V19, P59 WoS
|
| 81 | 6 | SANCHEZCESPEDES M, 1999, ONCOGENE, V18, P5843 WoS
|
| 82 | 6 | CAMPBELL SL, 1998, ONCOGENE, V17, P1395 WoS
|
| 83 | 5 | ESTELLER M, 2000, CANCER RES, V60, P2368 WoS
|
| 84 | 5 | GERADTS J, 1999, CLIN CANCER RES, V5, P791 WoS
|
| 85 | 5 | MAYO MW, 1997, SCIENCE, V278, P1812 WoS
|
| 86 | 5 | OSADA H, 2001, CANCER RES, V61, P8331 WoS
|
| 87 | 5 | BRAGA E, 1999, FEBS LETT, V454, P215 WoS
|
| 88 | 5 | TOYOTA M, 1999, P NATL ACAD SCI USA, V96, P8681 WoS
|
| 89 | 5 | HERMAN JG, 1998, P NATL ACAD SCI USA, V95, P6870 WoS
|
| 90 | 5 | SOZZI G, 1997, CANCER RES, V57, P2121 WoS
|
| 91 | 5 | MATSUMOTO S, 1997, GENE CHROMOSOME CANC, V20, P268 WoS
|
| 92 | 5 | SEKIDO Y, 2001, CANC PRINCIPLES PRAC, P917 WoS
|
| 93 | 5 | TSENG JE, 1999, CANCER RES, V59, P4798 WoS
|
| 94 | 5 | SIPRASHVILI Z, 1997, P NATL ACAD SCI USA, V94, P13771 WoS
|
| 95 | 5 | FORGACS E, 1998, ONCOGENE, V17, P1557 WoS
|
| 96 | 5 | CROCE CM, 1999, J CLIN ONCOL, V17, P1618 WoS
|
| 97 | 5 | GERADTS J, 2000, BRIT J CANCER, V82, P1191 WoS
|
| 98 | 5 | BAYLIN SB, 2001, HUM MOL GENET, V10, P687 WoS
|
| 99 | 5 | WALES MM, 1995, NAT MED, V1, P570 WoS
|
| 100 | 5 | WANG SS, 1998, SCIENCE, V282, P284 WoS
|